Engineering and combining oncolytic measles virus for cancer therapy

Cancer immunotherapy using tumor-selective, oncolytic viruses is an emerging therapeutic option for solid and hematologic malignancies. A considerable variety of viruses ranging from small picornaviruses to large poxviruses are currently being investigated as potential candidates. In the early days...

Descripción completa

Detalles Bibliográficos
Autores principales: Leber, Mathias F., Neault, Serge, Jirovec, Elise, Barkley, Russell, Said, Aida, Bell, John C., Ungerechts, Guy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333629/
https://www.ncbi.nlm.nih.gov/pubmed/32718830
http://dx.doi.org/10.1016/j.cytogfr.2020.07.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333629/
https://www.ncbi.nlm.nih.gov/pubmed/32718830
http://dx.doi.org/10.1016/j.cytogfr.2020.07.005

Ejemplares similares